{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:54:58Z","timestamp":1740167698715,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40119-024-00387-0","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:07:54Z","timestamp":1730718474000},"page":"761-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03192774","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Danial","family":"Amoey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Samy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Elbasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Landt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arief","family":"Kurniadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"T\u00f6lg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Richardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4809-5371","authenticated-orcid":false,"given":"Nader","family":"Mankerious","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"issue":"21","key":"387_CR1","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","volume":"141","author":"S Yadgir","year":"2020","unstructured":"Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017. Circulation. 2020;141(21):1670\u201380.","journal-title":"Circulation"},{"issue":"24","key":"387_CR2","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1001\/jama.2021.2133","volume":"325","author":"LJ Davidson","year":"2021","unstructured":"Davidson LJ, Davidson CJ. Transcatheter treatment of valvular heart disease: a review. JAMA. 2021;325(24):2480\u201394.","journal-title":"JAMA"},{"issue":"7","key":"387_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"9","key":"387_CR4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jcin.2016.01.037","volume":"9","author":"G Tarantini","year":"2016","unstructured":"Tarantini G, Mojoli M, Windecker S, Wendler O, Lefevre T, Saia F, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT Prospective Multicenter Registry. JACC Cardiovasc Interv. 2016;9(9):937\u201346.","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"387_CR5","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187\u201398.","journal-title":"N Engl J Med"},{"issue":"6","key":"387_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011036","volume":"8","author":"G Delesalle","year":"2019","unstructured":"Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8(6): e011036.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"387_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/ATVBAHA.117.306995","volume":"37","author":"M Hoffman","year":"2017","unstructured":"Hoffman M, Monroe DM. Impact of non-vitamin K antagonist oral anticoagulants from a basic science perspective. Arterioscler Thromb Vasc Biol. 2017;37(10):1812\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9921","key":"387_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362.","journal-title":"Lancet"},{"issue":"5","key":"387_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"8","key":"387_CR10","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.4244\/EIJY15M11_12","volume":"12","author":"A Sannino","year":"2016","unstructured":"Sannino A, Gargiulo G, Schiattarella GG, Perrino C, Stabile E, Losi MA, et al. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2016;12(8):e1047\u201356.","journal-title":"EuroIntervention"},{"issue":"6","key":"387_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.amjmed.2018.12.036","volume":"132","author":"G Patti","year":"2019","unstructured":"Patti G, Pecen L, Lucerna M, Huber K, Rohla M, Renda G, et al. Net clinical benefit of non-vitamin K antagonist vs vitamin K antagonist anticoagulants in elderly patients with atrial fibrillation. Am J Med. 2019;132(6):749-57e5.","journal-title":"Am J Med"},{"issue":"1","key":"387_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40119-018-0107-0","volume":"7","author":"A Bromley","year":"2018","unstructured":"Bromley A, Plitt A. A review of the role of non-vitamin K oral anticoagulants in the acute and long-term treatment of venous thromboembolism. Cardiol Ther. 2018;7(1):1\u201313.","journal-title":"Cardiol Ther"},{"issue":"12","key":"387_CR13","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.clinthera.2018.10.009","volume":"40","author":"AA Coulis","year":"2018","unstructured":"Coulis AA, Mackey WC. A review of the efficacy and safety profiles of the novel oral anticoagulants in the treatment and prevention of venous thromboembolism. Clin Ther. 2018;40(12):2140\u201367.","journal-title":"Clin Ther"},{"issue":"29","key":"387_CR14","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","volume":"43","author":"JP Collet","year":"2022","unstructured":"Collet JP, Van Belle E, Thiele H, Berti S, Lhermusier T, Manigold T, et al. Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J. 2022;43(29):2783\u201397.","journal-title":"Eur Heart J"},{"issue":"2","key":"387_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1911425","volume":"382","author":"GD Dangas","year":"2020","unstructured":"Dangas GD, Tijssen JGP, Wohrle J, Sondergaard L, Gilard M, Mollmann H, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382(2):120\u20139.","journal-title":"N Engl J Med"},{"issue":"5","key":"387_CR16","first-page":"e35","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35\u201371.","journal-title":"Circulation"},{"issue":"3","key":"387_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcin.2023.11.038","volume":"17","author":"B Alaour","year":"2024","unstructured":"Alaour B, Ferrari E, Heg D, Tueller D, Pilgrim T, Muller O, et al. Non-vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2024;17(3):405\u201318.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"387_CR18","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612\u201376.","journal-title":"Europace"},{"issue":"23","key":"387_CR19","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1016\/j.jacc.2017.03.600","volume":"69","author":"X Yao","year":"2017","unstructured":"Yao X, Shah ND, Sangaralingham LR, Gersh BJ, Noseworthy PA. Non-Vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction. J Am Coll Cardiol. 2017;69(23):2779\u201390.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"387_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E, Warden BA. direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13): e017559.","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"387_CR21","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","volume":"60","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"387_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014108","volume":"9","author":"S Sanghai","year":"2020","unstructured":"Sanghai S, Wong C, Wang Z, Clive P, Tran W, Waring M, et al. Rates of potentially inappropriate dosing of direct-acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE-AF Study. J Am Heart Assoc. 2020;9(6): e014108.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"387_CR23","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/jcm12031224","volume":"12","author":"P Diez-Villanueva","year":"2023","unstructured":"Diez-Villanueva P, Cosin-Sales J, Roldan-Schilling V, Barrios V, Riba-Artes D, Gavin-Sebastian O, et al. Use of direct acting oral anticoagulants in elderly patients with atrial fibrillation: a multicenter, cross-sectional study in Spain. J Clin Med. 2023;12(3):1224.","journal-title":"J Clin Med"},{"issue":"9","key":"387_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","volume":"107","author":"NA Geis","year":"2018","unstructured":"Geis NA, Kiriakou C, Chorianopoulos E, Uhlmann L, Katus HA, Bekeredjian R. NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiol. 2018;107(9):799\u2013806.","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"387_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/heartjnl-2022-321114","volume":"109","author":"V Caso","year":"2023","unstructured":"Caso V, de Groot JR, Sanmartin Fernandez M, Segura T, Blomstrom-Lundqvist C, Hargroves D, et al. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis. Heart. 2023;109(3):178\u201385.","journal-title":"Heart"},{"issue":"2","key":"387_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4244\/EIJV7I2A32","volume":"7","author":"NM Van Mieghem","year":"2011","unstructured":"Van Mieghem NM, Nuis RJ, Tzikas A, Piazza N, Schultz C, Serruys PW, et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7(2):184\u201391.","journal-title":"EuroIntervention"},{"issue":"2","key":"387_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11239-006-5206-4","volume":"21","author":"KM Twomley","year":"2006","unstructured":"Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis. 2006;21(2):167\u201374.","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"387_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/eurheartj\/ehp552","volume":"31","author":"R Bagur","year":"2010","unstructured":"Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865\u201374.","journal-title":"Eur Heart J"},{"issue":"6","key":"387_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/archsurg.1997.01430300062013","volume":"132","author":"FA Moore","year":"1997","unstructured":"Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132(6):620\u20134.","journal-title":"Arch Surg"},{"key":"387_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amjcard.2020.12.062","volume":"144","author":"A Sugrue","year":"2021","unstructured":"Sugrue A, Sanborn D, Amin M, Farwati M, Sridhar H, Ahmed A, et al. Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation. Am J Cardiol. 2021;144:52\u20139.","journal-title":"Am J Cardiol"},{"key":"387_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.907912","volume":"13","author":"DC Amoey","year":"2022","unstructured":"Amoey DC, Thranitz J, Munte TF, Royl G. Acute stroke and atrial fibrillation: risk of incorrect NOAC dosage when estimating renal function from plasma creatinine only. Front Neurol. 2022;13: 907912.","journal-title":"Front Neurol"},{"issue":"3","key":"387_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151\u201364.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"387_CR33","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1161\/STROKEAHA.120.028934","volume":"51","author":"JB Wetmore","year":"2020","unstructured":"Wetmore JB, Roetker NS, Yan H, Reyes JL, Herzog CA. Direct-acting oral anticoagulants versus warfarin in Medicare patients with chronic kidney disease and atrial fibrillation. Stroke. 2020;51(8):2364\u201373.","journal-title":"Stroke"},{"issue":"11","key":"387_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jacc.2014.05.065","volume":"64","author":"A Cuker","year":"2014","unstructured":"Cuker A, Siegal DM, Crowther MA, Garcia DA. Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. J Am Coll Cardiol. 2014;64(11):1128\u201339.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"387_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2215\/CJN.02870707","volume":"3","author":"AC Baxmann","year":"2008","unstructured":"Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3(2):348\u201354.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"387_CR36","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1182\/blood-2012-12-453076","volume":"121","author":"A Tripodi","year":"2013","unstructured":"Tripodi A. The laboratory and the direct oral anticoagulants. Blood. 2013;121(20):4032\u20135.","journal-title":"Blood"},{"issue":"3","key":"387_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s11239-020-02143-2","volume":"50","author":"F Hartig","year":"2020","unstructured":"Hartig F, Birschmann I, Peter A, Horber S, Ebner M, Sonnleitner M, et al. Point-of-care testing of coagulation in patients treated with edoxaban. J Thromb Thrombolysis. 2020;50(3):632\u20139.","journal-title":"J Thromb Thrombolysis"},{"issue":"10333","key":"387_CR38","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(22)00456-1","volume":"399","author":"JP Piccini","year":"2022","unstructured":"Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, et al. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Lancet. 2022;399(10333):1383\u201390.","journal-title":"Lancet"},{"issue":"11","key":"387_CR39","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"3","key":"387_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.amjcard.2018.10.042","volume":"123","author":"A Azarbal","year":"2019","unstructured":"Azarbal A, Malenka DJ, Huang YL, Ross CS, Solomon RJ, DeVries JT, et al. Recovery of kidney dysfunction after transcatheter aortic valve implantation (from the Northern New England Cardiovascular Disease Study Group). Am J Cardiol. 2019;123(3):426\u201333.","journal-title":"Am J Cardiol"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-024-00387-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-024-00387-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T17:07:18Z","timestamp":1732900038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-024-00387-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["387"],"URL":"https:\/\/doi.org\/10.1007\/s40119-024-00387-0","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"type":"print","value":"2193-8261"},{"type":"electronic","value":"2193-6544"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nader Mankerious received speaker honoraria from BIOTRONIK and Boston Scientific. Gert Richardt received an institutional research grant from Boston Scientific. Gert Richardt is an Editorial Board member of Cardiology and Therapy. Gert Richardt was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Danial Amoey, Mohamed Samy, Karim Elbasha, Ahmad Alali, Martin Landt, Arief Kurniadi, Holger Nef, and Ralph T\u00f6lg have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Written informed consent was obtained from all patients for analysis of their anonymized data. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. The present study was approved by the ethics committee of Schleswig\u2013Holstein medical syndicate. Reference number: 168\u201311.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}